Guided Therapeutics (GTHP) Cash from Financing Activities (2011 - 2025)
Guided Therapeutics recorded quarterly Cash from Financing Activities of $267000.0 in Q4 2025, up 47.51% quarter-over-quarter from $181000.0 in Q3 2025, and down 49.24% year-over-year from $526000.0 in Q4 2024.
Guided Therapeutics' Cash from Financing Activities history runs 15 years deep, the most recent figure standing at $267000.0 for Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 49.24% year-over-year to $267000.0; the TTM figure through Dec 2025 stood at $745000.0 (down 18.67% YoY), while the FY2025 annual figure was $745000.0, down 18.67% from the prior year.
- Cash from Financing Activities came in at $267000.0 for Q4 2025 at Guided Therapeutics, up from $181000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $2.9 million in Q3 2022 to a low of -$154000.0 in Q3 2023.
- A 5-year average of $346600.0 and a median of $188500.0 in 2023 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities jumped 687.88% in 2022 and tumbled 300.0% in 2024, its largest moves.
- Guided Therapeutics' Cash from Financing Activities stood at -$53000.0 in 2021, then advanced by 20.75% to -$42000.0 in 2022, then jumped by 566.67% to $196000.0 in 2023, then soared by 168.37% to $526000.0 in 2024, then tumbled by 49.24% to $267000.0 in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $267000.0, $181000.0, and $239000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 267,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 267,000.00 |
| Dec 31, 2025 | 267,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | 526,000.00 |
| Dec 31, 2024 | 526,000.00 |
| Sep 30, 2024 | 392,000.00 |
| Sep 30, 2024 | 392,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | -46,000.00 |
| Mar 31, 2024 | -46,000.00 |
| Dec 31, 2023 | 196,000.00 |
| Dec 31, 2023 | 196,000.00 |
| Sep 30, 2023 | -154,000.00 |
| Sep 30, 2023 | -154,000.00 |
| Jun 30, 2023 | -41,000.00 |
| Jun 30, 2023 | -41,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | -42,000.00 |
| Dec 31, 2022 | -42,000.00 |
| Sep 30, 2022 | 2.86 Mn |
| Sep 30, 2022 | 2.86 Mn |
| Jun 30, 2022 | 87,000.00 |
| Jun 30, 2022 | 87,000.00 |
| Mar 31, 2022 | 275,000.00 |
| Mar 31, 2022 | 275,000.00 |
| Dec 31, 2021 | -53,000.00 |
| Dec 31, 2021 | -53,000.00 |
| Sep 30, 2021 | 363,000.00 |
| Sep 30, 2021 | 363,000.00 |
| Jun 30, 2021 | 371,000.00 |
| Jun 30, 2021 | 371,000.00 |
| Mar 31, 2021 | 1.39 Mn |
| Mar 31, 2021 | 1.39 Mn |
| Dec 31, 2020 | -68,000.00 |
| Dec 31, 2020 | -68,000.00 |
| Sep 30, 2020 | 424,000.00 |
| Sep 30, 2020 | 424,000.00 |
| Jun 30, 2020 | 1.15 Mn |
| Jun 30, 2020 | 1.15 Mn |
| Mar 31, 2020 | -348,000.00 |
| Mar 31, 2020 | -348,000.00 |
| Dec 31, 2019 | 1.10 Mn |
| Dec 31, 2019 | 1.10 Mn |
| Sep 30, 2019 | 228,000.00 |
| Sep 30, 2019 | 228,000.00 |
| Jun 30, 2019 | 182,000.00 |
| Jun 30, 2019 | 182,000.00 |
| Mar 31, 2019 | 192,000.00 |
| Mar 31, 2019 | 192,000.00 |
| Dec 31, 2018 | 241,000.00 |
| Dec 31, 2018 | 241,000.00 |
| Sep 30, 2018 | 446,000.00 |
| Sep 30, 2018 | 446,000.00 |
| Jun 30, 2018 | 207,000.00 |
| Jun 30, 2018 | 207,000.00 |
| Mar 31, 2018 | 470,000.00 |
| Mar 31, 2018 | 470,000.00 |
| Dec 31, 2017 | 590,000.00 |
| Dec 31, 2017 | 590,000.00 |
| Sep 30, 2017 | 270,000.00 |
| Sep 30, 2017 | 270,000.00 |
| Jun 30, 2017 | -123,000.00 |
| Jun 30, 2017 | -123,000.00 |
| Mar 31, 2017 | 394,000.00 |
| Mar 31, 2017 | 394,000.00 |
| Dec 31, 2016 | 207,000.00 |
| Dec 31, 2016 | 207,000.00 |
| Sep 30, 2016 | 48,000.00 |
| Sep 30, 2016 | 48,000.00 |
| Jun 30, 2016 | 550,000.00 |
| Jun 30, 2016 | 550,000.00 |
| Mar 31, 2016 | 976,000.00 |
| Mar 31, 2016 | 976,000.00 |
| Dec 31, 2015 | 322,000.00 |
| Dec 31, 2015 | 322,000.00 |
| Sep 30, 2015 | 596,000.00 |
| Sep 30, 2015 | 596,000.00 |
| Jun 30, 2015 | 2.52 Mn |
| Jun 30, 2015 | 2.52 Mn |
| Mar 31, 2015 | 482,000.00 |
| Mar 31, 2015 | 482,000.00 |
| Dec 31, 2014 | 1.60 Mn |
| Dec 31, 2014 | 1.60 Mn |
| Sep 30, 2014 | 1.57 Mn |
| Sep 30, 2014 | 1.57 Mn |
| Jun 30, 2014 | 2.42 Mn |
| Jun 30, 2014 | 2.42 Mn |
| Mar 31, 2014 | 400,000.00 |
| Mar 31, 2014 | 400,000.00 |
| Dec 31, 2013 | 1.31 Mn |
| Dec 31, 2013 | 1.31 Mn |
| Sep 30, 2013 | 115,000.00 |
| Sep 30, 2013 | 115,000.00 |
| Jun 30, 2013 | 2.33 Mn |
| Jun 30, 2013 | 2.33 Mn |
| Mar 31, 2013 | 1.48 Mn |
| Mar 31, 2013 | 1.48 Mn |
| Dec 31, 2012 | 41,000.00 |
| Dec 31, 2012 | 41,000.00 |
| Sep 30, 2012 | 2.34 Mn |
| Sep 30, 2012 | 2.34 Mn |
| Jun 30, 2012 | 555,000.00 |
| Jun 30, 2012 | 555,000.00 |
| Mar 31, 2012 | 124,000.00 |
| Mar 31, 2012 | 124,000.00 |
| Dec 31, 2011 | 2.30 Mn |
| Dec 31, 2011 | 2.30 Mn |
| Sep 30, 2011 | -61,000.00 |
| Sep 30, 2011 | -61,000.00 |
| Jun 30, 2011 | 6,000.00 |
| Jun 30, 2011 | 6,000.00 |
| Mar 31, 2011 | 127,000.00 |
| Mar 31, 2011 | 127,000.00 |